Search results
Results from the WOW.Com Content Network
Katalin "Kati" Karikó (Hungarian: Karikó Katalin, pronounced [ˈkɒrikoː ˌkɒtɒlin]; born 17 January 1955) is a Hungarian-American [2] biochemist who specializes in ribonucleic acid ()-mediated mechanisms, particularly in vitro-transcribed messenger RNA (mRNA) for protein replacement therapy. [3]
Scripps Research Institute: 2001 National Academy of Sciences (US) Kaesberg, Paul: University of Wisconsin, Madison: 1991 National Academy of Sciences (US) Khorana, H. Gobind: 1922–2011 Massachusetts Institute of Technology: 1966 National Academy of Sciences (US), 1968 Nobel Prize in Physiology or Medicine, 1968 Horwitz Prize, 1968 Lasker ...
Jon Asher Wolff (September 25, 1956 – April 17, 2020) was an American geneticist.He was the lead author on a 1990 study published in the journal Science that first suggested the possibility of synthesizing mRNA in a laboratory to trigger the production of a desired protein.
Here are five things to know about Karikó and Weissman’s game-changing research and mRNA vaccines. What mRNA does. Messenger RNA, or mRNA, is a form of nucleic acid that tells cells what to do ...
Physician-scientist Margaret Liu stated that the efficacy of the new COVID-19 mRNA vaccines could be due to the "sheer volume of resources" that went into development, or that the vaccines might be "triggering a nonspecific inflammatory response to the mRNA that could be heightening its specific immune response, given that the modified ...
Prior to studying medicine, Robert Malone studied computer science at Santa Barbara City College for two years, acting as a teaching assistant in 1981. [2] [8] He received his BS in biochemistry from the University of California, Davis in 1984, his MS in biology from the University of California, San Diego in 1988, and his MD from Northwestern University Feinberg School of Medicine in 1991.
Kathrin U. Jansen (born 1958) is the former [1] Head of Vaccine Research and Development at Pfizer.She previously led the development of the HPV vaccine and newer versions of the pneumococcal conjugate vaccine (), and is working with BioNTech to create a COVID-19 vaccine using mRNA (Pfizer–BioNTech COVID-19 vaccine) that was approved for Emergency Use Authorization in the United States on ...
In 2007, Moore moved her research group to the Biochemistry and Molecular Pharmacology Department at the University of Massachusetts Chan Medical School (UMass Med). [ 9 ] [ 10 ] In 2011, Moore was the recipient of the American Society for Biochemistry and Molecular Biology 's William C. Rose Award [ 11 ] for excellence in mentoring.